elisa laboratory activity - images-na.ssl-images-amazon.com

The Biotechnology Education Company ®

EDVOTEK, Inc. • 1-800-EDVOTEK • www.edvotek.com

EVT 2011_07_25AM

EDVO-Kit #

278Quantitative ELISA Laboratory Activity

Storage: See Page 3 for specifi c storage instructions

EXPERIMENT OBJECTIVE:

The objective of this experiment is to perform and master the experimental concepts and methodology involved

with enzyme linked immunosorbent (ELISA) assays. This ELISA experiment is designed to detect circulating

IgG directed towards two antigens. Observations in this experiment include specifi city of antibodies, the effect of dilution on ELISA reactions, color

development and quantitation.

Updated

Revised

and

http://www.edvotek.com

2The Biotechnology Education Company® • 1-800-EDVOTEK • www.edvotek.com

Quantitative ELISA Laboratory Activity

EVT 2011_07_25AM

All components are intended for educational research only. They are not to be used for diagnostic or drug purposes, nor administered to or con-sumed by humans or animals.

THIS EXPERIMENT DOES NOT CONTAIN HUMAN DNA. None of the experiment components are derived from human sources.

EDVOTEK and The Biotechnology Education Company are trademarks of EDVOTEK, Inc.

Page

Experiment Components 3

Experiment Requirements 3

Background Information 4

Experiment Procedures

Experiment Overview and General Instructions 6

The Enzyme Linked Immunosorbent Assay (ELISA) 8

Study Questions 14

Instructor’s Guidelines

Notes to the Instructor 15

Pre-Lab Preparations 16

Quick Reference Tables 18

Avoiding Common Pitfalls 18

Expected Results 19

Study Questions and Answers 20

Material Safety Data Sheets 21

Table of Contents


3

278278Experiment #


EVT 2011_07_25AM

EDVOTEK - The Biotechnology Education Company® 1-800-EDVOTEK • www.edvotek.com

FAX: (301) 340-0582 • email: [email protected]

A Antigen 1B Antigen 2 C Primary Antibody 1D Primary Antibody 2E Secondary Antibody F Gelatin (blocking agent)G Hydrogen Peroxide, stabilizedH Phosphate buffered saline concentrateI Aminosalicylic acid (Peroxide co-substrate) • Microtiter plates• Transfer pipets• Microcentrifuge tubes• Plastic tubes (15 ml and 50 ml)

None of the components have been prepared from human sources.

This experiment is designed for 6 groups.

Upon receipt, store the perishable components (A-I) in the refrigerator.

Experiment Components

Requirements

• Distilled or deionized water• Beakers or fl asks• 37° C Incubation oven• Disposable lab gloves• Safety goggles• Automatic micropipets, 0-50 µl and tips (recommended)

Make sure glassware is clean, dry and free of soap residue.

For convenience, additional disposable transfer pipets (Cat. #632) can be purchased for liquid removal and washing steps.

Now with NEW

Substrate!


mailto:[email protected]

4

Duplication of this document, in conjunction with use of accompanying reagents, is permitted for classroom/laboratory use only. This document, or any part, may not be reproduced or distributed for any other purpose without the written consent of EDVOTEK, Inc. Copyright © 2000, 2005, 2009, 2011, EDVOTEK, Inc., all rights reserved. EVT 2011_07_25AM

The Biotechnology Education Company® • 1-800-EDVOTEK • www.edvotek.com

Quantitative ELISA Laboratory Activity278278 Experiment

Antibodies are specifi c human and animal proteins that are produced by white blood cells in response to foreign material. Examples of such foreign material, known as antigens, include infectious agents and various environmental "non-self" materials. Biological anti-gens are high molecular weight biomolecules such as proteins, carbohydrates and nucleic acids which can be circulating freely or as part of a complex such as part of a virus coat or bacterial cell surface. Antibodies are made in response to antigens. They bind to antigens and play a signifi cant role in the subsequent removal of such materials from circulation. For example, exposure to an infectious agent causes the individual to mount an antibody response which eventually results in plasma antibody molecules that bind to different viral proteins (and/or different areas of the same polypeptide).

When an antibody binds to a specifi c biological antigen, it can recognize specifi c chemical charges, sequences or structural conformational elements. These structural binding char-acteristics make up the specifi c fi ngerprint for an antigen. Each antibody molecule can bind two antigen molecules. This recognition and binding is highly specifi c and makes possible the differentiation between two circulating viruses that may be very closely related, as in the case of two strains of the same virus.

When an antigen and its antibodies form insoluble complexes, this highly specifi c binding reaction is known as immunoprecipitation. Precipitation of the complex is the result of various polyclonal antibodies binding to the antigens to form a network. In the tradi-tional immunoprecipitation assay, antibodies are obtained from the serum of an animal exposed to the specifi c antigen. The serum, also known as plasma, is prepared by the removal of red blood cells. It contains the specifi c proteins for that particular animal and antibodies against a "non-self" antigen that is introduced in the animal by either design or an infection. Antibodies are purifi ed from animal sera samples and can be used to detect particular antigens, such as human infectious agents.

Description of the Immunological Screening Test

Enzyme linked immunosorbent assay (ELISA) tests were originally developed for anti-body measurement. These immunoassays have also been adapted to successfully detect samples that contain antigens. ELISAs are done in microtiter plates which are generally made of polystyrene or polyvinyl chloride. The plates are somewhat transparent and contain many small wells, in which liquid samples are deposited. First, the antigens are added to the wells where some remain adsorbed by hydrophobic association to the walls after washing away the excess. The antigens can be the whole infecting agent, such as a virus or lysate, specifi c proteins, or a mixture of the two. There is no specifi city involved with the adsorption process although some substances may exhibit low binding to the walls. In certain cases the antigens can be covalently cross-linked to the plastic using UV light. After washing away unadsorbed material, the unoccupied sites on the walls of the plastic wells are blocked with gelatin, milk proteins or bovine serum albumin. In this experiment, positive samples will have antibodies that will bind to the preadsorbed antigens in wells. If the primary antibody has remained in a well, then the secondary an-tibody will bind to it and also remain attached after washing. These secondary antibod-ies are usually raised in rabbits and goats immunized with "non-self" IgG fractions. The second IgG antibodies are purifi ed and covalently cross- linked to horseradish peroxidase. This modifi cation does not signifi cantly affect the binding specifi city and affi nity of the antibody or the enzymatic activity of the peroxidase.

Background Information


5



278278Experiment


After washing, a solution containing hydrogen peroxide and aminosalicylate is added to each well. Peroxidase possesses a high catalytic activity and can exceed turnover rates of 106 per second. Consequently, amplifi cation of a positive sample can occur over several orders of magnitude. Many hydrogen donor co-substrates can be used by peroxidase. These co-substrates include o-diansidine, aminoantipyrine, aminosalicylic acid and numer-ous phenolic compounds that develop color upon oxidation.

The substrate solution added is nearly colorless. Peroxidase converts the peroxide to H2O + O2 using the salicylate as the hydrogen donor. The oxidized salicylate is brown and can be easily observed in positive wells.

Figure 1 illustrated the ELISA assay. It should be noted that polyclonal antibody prepara-tions to a given antigen can have variable binding affi nities due to differences in the im-munological responses between animals. Different immunizations with the same antigen in the same animal can also produce variable binding affi nities. The use of monoclonal antibodies directed against a single epitope eliminates this variability. Western blot analysis of positive samples can be used to confi rm the presence and size of antibodies.

This ELISA experiment is designed to detect two separate circulating IgG molecules direct-ed towards two distinct antigens. Observations in this experiment include specifi city of antibodies, the effect of dilution on ELISA reactions, color development and quantitation.

Figure 1: ELISA “Sandwich”

Background Information

well

Anti-IgG (Rabbit)

Human Serum (IgG)

HIV Antigen

well

well

Substrate (S)(Reduced)(colorless)

Product (P)(Oxidized)

(color)

Human Serum (IgG)

HIV Antigen

Anti-IgG (Rabbit)

Human Serum (IgG)

HIV Antigen

Horseradish peroxidase

Horseradish peroxidase

2H2O2 –> H20 + 2O2


6




Experiment Overview and General Instructions

EXPERIMENT OBJECTIVE:

The objective of this experiment is to perform and master the experimental concepts and methodology involved with enzyme linked immunosorbent (ELISA) assays. This ELISA ex-periment is designed to detect circulating IgG antibodies directed towards two antigens. Observations in this experiment include specifi city of antibodies, the effect of dilution on ELISA reactions, color development and quantitation.

LABORATORY SAFETY

1. Gloves and goggles should be worn routinely as good laboratory practice.

2. Exercise extreme caution when working with equipment which is used in conjunction with the heating and/or melting of reagents.

3. DO NOT MOUTH PIPET REAGENTS - USE PIPET PUMPS OR BULBS.

4. Always wash hands thoroughly with soap and water after handling contaminated materials.

LABORATORY NOTEBOOK RECORDINGS:

Address and record the following in your laboratory notebook or on a separate work-sheet.

Before starting the Experiment:

• Write a hypothesis that refl ects the experiment. • Predict experimental outcomes.

During the Experiment: • Record (draw) your observations, or photograph the results.

Following the Experiment: • Formulate an explanation from the results. • Determine what could be changed in the experiment if the experiment were

repeated. • Write a hypothesis that would refl ect this change.

Wear Gloves and Goggles


7



278278Experiment

Quantitative ELISA Laboratory ActivityExp

erimen

t Proced

ure

1. Equilibrate a 37° C incubation oven before starting the experi-ment.

2. Place the microtiter plate as shown in the fi gure at right and carefully mark the plate with your initials or lab group number

3. Using a permanent marker, label the columns 1-5 across the top and the rows A-H down the side.

4. As shown in the fi gure, draw lines across the plate between Rows B and C, Rows D and E, and Rows F and G. This will create four sections on the plate.

Microtiter plate

A

B

C

D

E

F

G

H

1 2 3 4 5

5. Label 4 large transfer pipets as follows (these are to be used for addition of reagents to the wells):

• PBS for Phosphate Buffered Saline • Ag1 for Antigen 1 • Ag2 for Antigen 2 • block for blocking agent 6. Label 2 small transfer pipets Ag1 and Ag2. These are to be used for removal of liquid from the wells.

7. Proceed to dilution of Primary Antibodies 1 and 2 on pages 8 and 9.

Experiment Overview and General Instructions

CAUTION: To avoid cross-contamination and false results, use the appropriately labelled plastic transfer pipet for liquid removals and washes as outlined in the experimental procedures.

1 Half piece of microtiter plate1 Tube labeled "Ag1"1 Tube labeled "Ag2"1 Tube labeled "block"1 Tube labeled "Ab1 - 1"1 Tube labeled "Ab2 -1"1 Tube labeled "2°Ab"1 Automatic micropipet with tips (optional)11 Transfer pipets (large)11 Transfer pipet (small)1 Beaker containing PBS1 Empty beaker labeled "waste"1 Tube labeled "Substrate" (just before the last incubation)8 Microcentrifuge tubes

STUDENT MATERIALS:Each Lab Group Should Receive the following components prior to the start of the experiment procedure.


8




Exp

erim

ent

Pro

ced

ure

DILUTION OF PRIMARY ANTIBODIES 1 AND 2

Primary Antibody 1

1. Label four tubes as follows: “Ab1 - 2”. This is your 1:1600 dilution. “Ab1 - 3”. This is your 1:6400 dilution. “Ab1 - 4”. This is your 1:25,600 dilution. “Ab1 - 5”. This is your 1:102,400 dilution.

2. Add 6 drops (330 µl) of PBS to each tube.

3. Obtain the “Ab1 - 1” tube from your instructor. This is your 1:400 dilution of Primary Antibody 1.

4. Use a fresh pipet tip or a fresh large transfer pipet to add 2 drops (110 µl) of “Ab1 - 1” Primary Antibody to the tube labeled “Ab1 - 2”. Pipet the solution up and down, cap the tube and mix well.

5. Use the same large transfer pipet to add 2 drops of “Ab1 - 2” to the tube labeled “Ab1 - 3”. Pipet the solution up and down, cap the tube and mix well.



See NOTE at bottom of page 9 for storage of Ab1 or just store diluted Ab1 in the refrigerator until needed.

If using a micropi-pet for diluting the antibodies, dilute the 1:400 antibody solu-tion 1:4 by combining 110 μl 1:400 antibody with 330 μl diluted PBS. Continue diluting the antibody 4-fold, up to 1:102,400.

2 drops(110 µl)

2 drops(110 µl)

2 drops(110 µl)

2 drops(110 µl)

6 drops(330 µl PBS)

(Obtainedfrom instructor)




1:400 1:1600 1:6400 1:25,600 1:102,400

Ab1 - 1 Ab1 - 2 Ab1 - 3 Ab1 - 4 Ab1 - 5

Quantitative Enzyme Linked Immunosorbent Assay (ELISA)


9



278278Experiment


erimen

t Proced

ure

Primary Antibody 2

1. Label four tubes as follows: “Ab2 - 2”. This is your 1:1600 dilution. “Ab2 - 3”. This is your 1:6400 dilution. “Ab2 - 4”. This is your 1:25,600 dilution. “Ab2 - 5”. This is your 1:102,400 dilution.

2. Add 6 drops (330 µl) of PBS to each tube.

3. Obtain the “Ab2 - 1” tube from your instructor. This is your 1:400 dilution of Primary Antibody 2.

4. Use a fresh pipet tip or a fresh large transfer pipet to add 2 drops (110 µl) of “Ab2 - 1” Primary Antibody to the tube labeled “Ab2 - 2”. Pipet the solution up and down, cap the tube and mix well.




2 drops(110 µl)

2 drops(110 µl)

2 drops(110 µl)

2 drops(110 µl)


(Obtainedfrom instructor)




1:400 1:1600 1:6400 1:25,600 1:102,400

Ab2 - 1 Ab2 - 2 Ab2 - 3 Ab2 - 4 Ab2 - 5


NOTE: Keep the Primary Antibodies 1 and 2 and their dilutions in the refrigerator until needed.


10




Exp

erim

ent

Pro

ced

ure

1. Orient the microtiter plate so the wells labeled as columns 1-5 are on the horizontal axis and the wells labelled as rows A-H are on the verti-cal axis (as shown in the fi gure at left).

2. Read through the instructions and study the fi gure on the previous page before beginning to add antigens to the wells. Refer to the fi g-ure often during the experimental procedure to avoid making errors.

ADDITION OF ANTIGENS:

3. Using the appropriately labelled large transfer pipet or fresh pipet tip for each reagent, add reagents to the wells as described below.

• Add 50 µl or 1 drop of Antigen 1 to the wells 1 - 5 in rows A, B, C and D.

• Add 50 µl or 1 drop of Antigen 2 to the wells 1 - 5 in rows E, F, G

and H. 4. Incubate the plate at room temperature for 5 minutes.

The Enzyme Linked Immunosorbent Assay (ELISA)

Note:

None of the wells in column 6 will be used in this experiment.

LIQUID REMOVAL OF ANTIGENS:

In the steps which follow, use the appropriately labelled small transfer pipets to remove liquid from the wells. It is important to follow directions carefully to avoid cross-contami-nation of the wells. Save the pipets for later steps.

5. Using the small pipet labelled "Ag1", remove the liquid from wells in rows A - D.

6. Using the small pipet labelled "Ag 2", remove the liquid from wells in rows E - H.

PBS WASH AND LIQUID REMOVAL OF PBS

7. Using the large transfer pipet labelled "PBS" add Phosphate Buffered Saline to wells 1 - 5 in all the rows. Fill until each well is almost full. If using an automatic micropi-pet, add 200 µl of PBS to each of the wells.

8. Remove the PBS from the wells using the same procedures outlined in steps 5 and 6.

A

B

C

D

E

F

G

H

1 2 3 4 5


11



278278Experiment


erimen

t Proced

ure


ADDITION OF BLOCKING AGENT

9. Using a fresh pipet tip or the large transfer pipet labelled “block”, add 50 µl or 1 drop of “block” (blocking agent) to each of the wells in columns 1 - 5 in all rows (exclude wells in column 6).

10. Incubate the plate for 10 minutes at 37° C.

11. Using the small pipet labelled “Ag1”, remove the liquid from wells 1 - 5 in rows A - D.

12. Using the small pipet labelled “Ag 2”, remove the liquid from wells 1 -5 in rows E - H.

PBS WASH AND LIQUID REMOVAL OF BLOCKING AGENT

13. Using the large pipet labelled “PBS” add Phosphate Buffered Saline to all the wells. Fill until each well is almost full. If using a micropipet, add 200 µl of PBS to each of the wells.

14. Remove the PBS from the wells using the same procedures outlined in steps 11 and 12. Discard the small pipets when fi nished.

OPTIONAL STOPPING POINT:

The experiment can be stopped after addition of PBS (step 13) and resumed during next lab period. Cover microtiter plates with parafi lm or plastic wrap and refrigerate overnight.

Use the appropri-ately labeled plastic transfer pipet for liquid removals and washes to avoid cross-contami-nation and false results.


12




Exp

erim

ent

Pro

ced

ure

ADDITION OF PRIMARY ANTIBODIES 1 & 2 (PREPARED ON PAGES 8 & 9)

1. Label 3 large transfer pipets "PBS", "Ab1", and "Ab2". Use a fresh pipet tip or the appropriately labelled large transfer pipet for addition of PBS and each antibody.

2. Add 50 µl or 1 drop of PBS to the wells in rows C and E.

3. Add 50 µl or 1 drop of “Ab1 - 5” to wells A5, B5, and F5.





8. Add 50 µl or 1 drop of “Ab2 - 5” to wells D5, G5, and H5.





13. Incubate the plate at 37° C for 30 minutes.

LIQUID REMOVAL OF ANTIBODIES:

14. Label 4 small transfer pipets “AB”, “CD”, “EF”, and “GH”.

15. Starting with the most dilute antibody (column 5) in rows A and B, use the pipet labelled “AB” to remove the liquid from the wells moving from right to left (i.e. remove in order A5, B5, A4, B4, A3, B3, A2, B2, A1, B1).

16. Repeat the procedure with the other rows (C-H) using the appropriately labelled transfer pipets.

NOTE:To add primary antibody, use the same pipet going from lowest concentration to high-est concentration. (Use a fresh transfer pipet or a fresh pipet tip for addition of Antibody 1, Antibody 2, and PBS.)


blank

blank

blank

blank

blank

A

B

C

D

E

F

G

H

1 2 3 4 5

Ab1:1 Ab1:2 Ab1:3 Ab1:4 Ab1:5

Ab1:1 Ab1:2 Ab1:3 Ab1:4 Ab1:5

PBS PBS PBS PBS PBS

PBSPBS PBS PBS PBS

6

blank

blank

blank

Ab1:1 Ab1:2 Ab1:3 Ab1:4 Ab1:5

Ab2:1 Ab2:2 Ab2:3 Ab2:4 Ab2:5

Ab2:1 Ab2:2 Ab2:3 Ab2:4 Ab2:5

Ab2:1 Ab2:2 Ab2:3 Ab2:4 Ab2:5

Use the appropriately labeled plastic transfer pipet for liquid remov-als and washes to avoid cross-contamination and false results.


13



278278Experiment


erimen

t Proced

ure



17. Using the large pipet labelled “PBS” add Phosphate Buffered Saline to all the wells. Fill until each well is almost full. If using a micropipet, add 200 µl to each well.

18. Remove the PBS from the wells using the same procedures outlined in steps 2 and 3. Discard transfer pipets.

ADDITION OF SECONDARY ANTIBODY

19. Use a fresh pipet tip or a large transfer pipet to add 50 µl or 1 drop of Secondary Antibody to each of the wells in rows A-H (all 40 wells).

20. Incubate the plate at 37° C for 15 minutes.

LIQUID REMOVAL OF SECONDARY ANTIBODIES

21. Label 4 small transfer pipets “AB”, “CD”, “EF”, and “GH”.

22. Starting with the most dilute antibody (column 5) in rows A and B, use the pipet labelled “AB” to remove the liquid from the wells moving from right to left (i.e. remove, in order A5, B5, A4, B4, A3, B3, A2, B2, A1, B1).

23. Repeat the procedure with the other rows (C-H) using the appropriately labeled transfer pipets.


24. Using the large pipet labelled “PBS” add Phosphate Buffered Saline to all the wells. Fill until each well is almost full. If using a micropipet, add 200 µl to each well.

25. Remove the PBS from the wells using the same procedures outlined in steps 22 and 23.

ADDITION OF SUBSTRATE

26. Start with column 5 and move to the left - use a fresh pipet tip or a fresh large trans-fer pipet to add 50 µl or 1 drop of Substrate to 40 wells (exclude wells in column 6).

27. Incubate at room temperature for 5 minutes.

28. Periodically observe the plate for color development.

29. If color is not fully developed after 5 minutes, incubate for a longer period of time.


14




Exp

erim

ent

Pro

ced

ure

Study Questions

Answer the following study questions in your laboratory notebook or on a separate worksheet.

1. To what do antibodies respond?

2. Can an antibody act as an antigen?

3. Describe the ELISA antigen antibody reactions.

4. Is a positive result always visualized as a brown color in the ELISA assay?


15

278278Experiment #


EVT 2011_07_25AM

EDVOTEK - The Biotechnology Education Company® 1-800-EDVOTEK • www.edvotek.com

FAX: (301) 340-0582 • email: [email protected]

Instructor’s Guide

Class size, length of laboratory sessions, and availability of equipment are factors which must be considered in planning and implementing this experi-ment with your students. These guidelines can be adapted to fi t your spe-cifi c set of circumstances. If you do not fi nd the answers to your questions in this section, a variety of resources are continuously being added to the EDVOTEK web site. Technical Service is available from 9:00 am to 6:00 pm, Eastern time zone. Call for help from our knowledgeable technical staff at 1-800-EDVOTEK (1-800-338-6835).

APPROXIMATE TIME REQUIREMENTS FOR PRE-LAB AND EXPERIMENTAL PROCEDURES

• Pre-lab preparation of biologicals and reagents takes approximately one and one-half hours.

• The student experimental activity requires approximately 2 hours with optional stopping points available.

Notes to the Instructor & Pre-Lab Preparations

Visit our web site for information about EDVOTEK's complete line of experiments for biotechnology

and biology education.

Visit the EDVOTEK web site often for continuously updated information.

Mon - Fri 9 am - 6 pm ET

(1-800-338-6835)

EDVO-TECH SERVICE

1-800-EDVOTEK

Mon - Fri9:00 am to 6:00 pm ET

FAX: (301) 340-0582Web: www.edvotek.comemail: [email protected]

Please have the following information ready:

• Experiment number and title• Kit lot number on box or tube• Literature version number (in lower right corner)• Approximate purchase date

Technical ServiceDepartment

OrderOnline





16



278278Experiment

Inst

ruct

or’

s G

uid

eInstructor’s Guide Quantitative ELISA

Laboratory Activity

PREPARATIONS BEFORE THE LAB

Microtiter Plates

1. As shown in the fi gure at right, orient the microtiter plates so that the numbers 1-12 are at the top and the letters A-H are on the left.

2. Cut each plate along the solid lines as shown in the fi gure. Each piece will be 6 wells on one axis and 8 wells on the other axis. Each lab group will receive one piece containing 48 wells.

PREPARATIONS ON THE DAY OF THE LAB

Preparation of Phosphate Buffered Saline

1. Add all of the Phosphate Buffered Saline concentrate (comp. H) to 360 ml of distilled water. Mix.

2. Label this diluted Phosphate Buffered saline as “PBS”.

3. Dispense 50 ml into small beakers for each of the 6 lab groups.

Antigens 1 and 2

1. Label 6 tubes “Ag1” and “Ag2” and dispense 1.5 ml Antigen 1 (comp. A) into the tubes labeled “Ag1” and 1.5 ml Antigen 2 (comp. B) into the tubes labeled “Ag2”.

2. Distribute one tube of “Ag1” and “Ag2” each per group.

Blocking Agent

1. If the Blocking agent has gelled, place the bottle in a 37° C waterbath or oven to melt the gelatin.

2. Label 6 larger test tubes “block” and dispense 3.0 ml Gelatin Blocking Agent (comp. F) into the tubes.

3. Distribute one tube of Blocking agent per group.

Pre-Lab Preparations

A

B

C

D

E

F

G

H

1 2 3 4 5 6 7 8 9 10 11 12

NOTES:

The Phosphate Buff-ered saline may pre-cipitate or crystalize. Warm the buffer in a 37° C water bath before using and check that there is no precipitate.

The blocking buffer will likely precipi-tate during storage. Warm @ 37° C for 5-10 minutes or until the precipitate has dissolved.


17



278278Experiment


Instru

ctor’s G

uid

eInstructor’s Guide

Primary Antibodies 1 and 2 (1:400)

1. Add 0.3 ml diluted PBS to tube C. Mix well and transfer the entire con-tents to a larger tube containing 5.7 ml diluted PBS. This is 1:400 Primary Antibody 1. Dispense 0.5 ml diluted Primary Antibody 1 (comp. C) into 6 tubes labeled "Ab1 - 1".

2. Distribute one tube of “Ab1 - 1” per group.

3. Add 0.3 ml diluted PBS to tube D. Mix well and transfer the entire con-tents to a larger tube containing 5.7 ml diluted PBS. This is 1:400 Primary Antibody 2. Dispense 0.5 ml diluted Primary Antibody 2 (comp. D) into 6 tubes labeled "Ab2 - 1".

4. Distribute one tube of “Ab2 - 1” per group.

Preparation of Secondary Antibody

1. Add 0.3 ml diluted PBS to the tube containing Secondary Antibody (comp. E). Add 18 ml diluted PBS into the 50 ml conical tube provided and transfer the entire contents of tube E into the PBS. Cap the tube and mix. Dispense 3.0 ml diluted secondary antibody into 6 tubes labeled "2°Ab".

2. Distribute one tube of “2°Ab” per group.

Preparation of Peroxidase Substrate During the Lab Experiment

Prepare 15 - 30 minutes before the last incubation:

1. Dispense 16 ml of diluted Phosphate buffered saline (PBS) to the second 50 ml tube provided.

2. Add all of the Aminosalicylic acid (I) to the 16 ml of PBS. Cap and mix thor-oughly by shaking and/or vortexing. There is usually undissolved material remaining.

3. Then add 1.8 ml of Hydrogen peroxide (G). Cap and mix.

4. Dispense 2.5 ml of the peroxidase substrate for each group.

5. Keep refrigerated in the dark until use.

NOTE:The sample volumes of primary antibodies 1 and 2 and the sec-ondary antibody are very small - the tubes should be centrifuged to collect the samples at the bottom of the tubes before they are diluted.


Quick Reference: The substrate is pre-pared for the peroxi-dase enzyme, which is attached to the anti-IgG peroxidase conju-gate (secondary anti-body). Prepare the substrate 15 - 30 min-utes before students require it for plate development (last incu-bation).


18



278278Experiment

Inst

ruct

or’

s G

uid

eInstructor’s Guide Quantitative ELISA

Laboratory Activity

PREPARATION OF EXPERIMENT REAGENTS

1 half piece of microtiter plate1 tube labeled "Ag1"1 tube labeled "Ag2"1 tube labeled "block"1 tube labeled "Ab1 - 1"1 tube labeled "Ab2 - 1"1 tube labeled "2°Ab"1 automatic micropipet with tips (optional)11 Transfer pipets (large)11 Transfer pipet (small)1 beaker containing PBS1 empty beaker labeled "waste"1 tube labeled "Substrate" (just before the last incubation)8 microcentrifuge tubes

STUDENT MATERIALSEach Lab Group Should Receive:

Dispense for each groupLabel

A Antigen 1 Ag1 1.5 mlB Antigen 2 Ag2 1.5 mlC + PBS Antibody 1 (1:400 dilution) Ab1 - 1 0.5 mlD + PBS Antibody 2 (1:400 dilution) Ab2 - 1 0.5 mlE + PBS Secondary Antibody 2°Ab 3.0 mlG + I + PBS Peroxidase Enzyme Substrate Substrate 2.5 mlH + dH2O Phosphate buffered saline PBS 50 mlF Gelatin (Blocking Agent) block 3.0 ml

* Components A, B, C, D, E, F can be dispensed before the actual day of the lab and stored in the refrigerator.


AVOIDING COMMON PITFALLS

1. Students should be advised to be very careful when transferring solutions into and out of the microliter plate wells.

2. Use only clean or appropriately la-beled pipets and avoid contaminating adjacent wells.

3. Do not attempt to empty the micro-titer wells by shaking it out. This will not work - it will result in contaminat-ing adjacent wells.

4. Wash the wells gently and slowly, without force.


19



278278Experiment


Instru

ctor’s G

uid

eInstructor’s Guide

Expected Results

1:400 1:1600 1:6400 1:25,600

A

B

CD

E

F

G

H

1 2 3 4 5

1:102,400

The idealized schematic at right shows representative results. Actual results may vary.


Please refer to the kit insert for the Answers to

Study Questions

21

278278Experiment

Material Safety Data SheetsFull-size (8.5 x 11”) pdf copy of MSDS is available at www. edvotek.com or by request.

Mat

eria

l Saf

ety

Dat

a S

hee

tM

ay b

e us

ed to

com

ply

with

OS

HA

's H

azar

d C

omm

unic

atio

nS

tand

ard.

29

CF

R 1

910.

1200

Sta

ndar

d m

ust b

e co

nsul

ted

for

spec

ific

requ

irem

ents

.

IDE

NT

ITY

(A

s U

sed

on L

abel

and

Lis

t)N

ote:

Bla

nk s

pace

s ar

e no

t per

mitt

ed.

If an

y ite

m is

not

ap

plic

able

, or

no in

form

atio

n is

ava

ilabl

e, th

e sp

ace

mus

t be

mar

ked

to in

dica

te th

at.

Sec

tio

n I

Man

ufac

ture

r's N

ame

Sec

tio

n II

- H

azar

do

us

Ing

red

ien

ts/Id

enti

fy In

form

atio

n

Em

erge

ncy

Tele

phon

e N

umbe

r

Tele

phon

e N

umbe

r fo

r in

form

atio

n

Dat

e P

repa

red

Sig

natu

re o

f Pre

pare

r (o

ptio

nal)

Add

ress

(N

umbe

r, S

tree

t, C

ity, S

tate

, Z

ip C

ode)

ED

VO

TE

K, I

nc.

1467

6 R

oth

geb

Dri

veR

ock

ville

, MD

208

50

Haz

ardo

us C

ompo

nent

s [S

peci

fic

Che

mic

al Id

entit

y; C

omm

on N

ame(

s)]

O

SH

A P

EL

AC

GIH

TLV

Oth

er L

imits

R

ecom

men

ded

% (

Opt

iona

l)

(301

) 25

1-59

90

(301

) 25

1-59

90

Boi

ling

Poi

nt

Sec

tio

n II

I - P

hys

ical

/Ch

emic

al C

har

acte

rist

ics

Unu

sual

Fire

and

Exp

losi

on H

azar

ds

Spe

cial

Fire

Fig

htin

g P

roce

dure

s

Vap

or P

ress

ure

(mm

Hg.

)

Vap

or D

ensi

ty (

AIR

= 1

)

Sol

ubili

ty in

Wat

er

App

eara

nce

and

Odo

r

Sec

tio

n IV

- P

hys

ical

/Ch

emic

al C

har

acte

rist

ics

Fla

sh P

oint

(M

etho

d U

sed)

Ext

ingu

ishi

ng M

edia

Fla

mm

able

Lim

itsU

EL

LEL

Mel

ting

Poi

nt

Eva

pora

tion

Rat

e(B

utyl

Ace

tate

= 1

)

Spe

cific

Gra

vity

(H

0 =

1)

2

EDVOTEK

®

A -

E 2

78

CA

S# 1

39-3

3-3

CA

S# 2

6628

-22-

8

V

ery

dilu

te

No

data

No

data

No

data

No

data

No

data

No

data

Solu

ble

Cle

ar li

quid

, no

odor

No

data

N.D

. = N

o da

ta

Dry

che

mic

al, c

arbo

n di

oxid

e, h

alon

. wat

er s

pray

or

stan

dard

foa

m

Mor

e co

ntai

ner

from

fir

e ar

ea if

pos

sibl

e. D

ike

fire

con

trol

w

ater

for

late

r di

spos

al

The

rmal

dec

ompo

sitio

n pr

oduc

ts m

ay in

clud

e to

xic

and

haza

rdou

sox

ides

of

carb

on, n

itrog

en, a

nd s

odiu

m

07/2

7/09

Sta

bilit

y

Sec

tio

n V

- R

eact

ivit

y D

ata

Uns

tabl

e

Sec

tio

n V

I - H

ealt

h H

azar

d D

ata

Inco

mpa

tibili

ty

Con

ditio

ns to

Avo

id

Rou

te(s

) of

Ent

ry:

Inha

latio

n?In

gest

ion?

Ski

n?

Oth

er

Sta

ble

Haz

ardo

us

Pol

ymer

izat

ion

May

Occ

urC

ondi

tions

to A

void

Will

Not

Occ

ur

Hea

lth H

azar

ds (

Acu

te a

nd C

hron

ic)

Car

cino

geni

city

:N

TP

?O

SH

A R

egul

atio

n?IA

RC

Mon

ogra

phs?

Sig

ns a

nd S

ympt

oms

of E

xpos

ure

Med

ical

Con

ditio

ns G

ener

ally

Agg

rava

ted

by E

xpos

ure

Em

erge

ncy

Firs

t Aid

Pro

cedu

res

Sec

tio

n V

II -

Pre

cau

tio

ns

for

Saf

e H

and

ling

an

d U

seS

teps

to b

e Ta

ken

in c

ase

Mat

eria

l is

Rel

ease

d fo

r S

pille

d

Was

te D

ispo

sal M

etho

d

Pre

caut

ions

to b

e Ta

ken

in H

andl

ing

and

Sto

ring

Oth

er P

reca

utio

ns

Sec

tio

n V

III -

Co

ntr

ol M

easu

res

Ven

tilat

ion

Loca

l Exh

aust

Spe

cial

Mec

hani

cal (

Gen

eral

)

Res

pira

tory

Pro

tect

ion

(Spe

cify

Typ

e)

Pro

tect

ive

Glo

ves

Oth

er P

rote

ctiv

e C

loth

ing

or E

quip

men

t

Wor

k/H

ygie

nic

Pra

ctic

es

Eye

Pro

tect

ion

Haz

ardo

us D

ecom

posi

tion

or B

ypro

duct

s

X

Exc

essi

ve h

eat,

spar

ks o

r op

en f

lam

e, p

rote

in d

enat

uran

ts

Aci

ds, a

lum

inum

, met

als,

oxi

dize

rs (

stro

ng)

The

rmal

dec

ompo

sitio

n pr

oduc

ts o

f tox

ic &

haz

ardo

us o

xide

sof

car

bon

and

nitr

ogen

X Yes

Yes

Yes

M

oder

atel

y to

xic

by in

gest

ion.

Sys

tem

atic

toxi

city

may

res

ult.

May

ch

elat

e le

ad, m

agne

sium

, zin

c, tr

ace

met

als

if p

rese

nt in

inte

stin

e. S

ensi

tivity

rea

ctio

ns -

ana

phyl

actic

sho

ck

Non

e

No

data

No

data

No

data

Muc

ous

mem

bran

e ir

rita

tion,

eye

/ski

n ir

rita

tion,

irri

tatin

g to

ga

stro

inte

stin

al s

yste

m

Ren

al o

r he

art d

isea

se, p

otas

sium

def

icie

ncy.

Ins

ulin

-dep

ende

nt d

iabe

tes,

seiz

ures

or

intr

acra

nial

lesi

ons

Tre

at s

ympt

omat

ical

ly a

nd s

uppo

rtiv

ely

Mop

up

with

abs

orpt

ive

mat

eria

l. C

onta

iner

ize

to d

ispo

se o

f pr

oper

ly

Obs

erve

fed

eral

, sta

te, a

nd lo

cal l

aws.

Stor

e aw

ay f

rom

str

ong

oxid

izer

s or

hea

t. A

void

eye

/ski

n co

ntac

t

Non

e

No

Non

e

Dilu

tion

vent

sys

Non

e

Yes

Spla

sh p

roof

gog

gles

Impe

rvio

us c

loth

ing

to p

reve

nt c

onta

ct

Em

erge

ncy

eye

was

h sh

ould

be

avai

labl

e

Che

mic

al c

artr

idge

res

pira

tor

with

ful

l fac

epie

ce a

nd o

rgan

ic v

apor

car

trid

ge

1121

5th

Str

eet

NW

Was

hin

gto

n D

C 2

0001

08-1

5-11

Mat

eria

l Saf

ety

Dat

a Sh

eet

May

be

use

d t

o c

om

ply

wit

h O

SHA

's H

azar

d C

om

mu

nic

atio

nSt

and

ard

. 29

CFR

191

0.12

00 S

tan

dar

d m

ust

be

con

sult

ed f

or

spec

ific

req

uir

emen

ts.

IDEN

TITY

(A

s U

sed

on

Lab

el a

nd

Lis

t)N

ote

: B

lan

k sp

aces

are

no

t p

erm

itte

d.

If a

ny

item

is n

ot

app

licab

le, o

r n

o in

form

atio

n is

ava

ilab

le, t

he

spac

e m

ust

b

e m

arke

d t

o in

dic

ate

that

.

Sect

ion

IM

anu

fact

ure

r's

Nam

e

Sect

ion

II -

Haz

ard

ou

s In

gre

die

nts

/Id

enti

fy In

form

atio

n

Emer

gen

cy T

elep

ho

ne

Nu

mb

er

Tele

ph

on

e N

um

ber

fo

r in

form

atio

n

Dat

e Pr

epar

ed

Sig

nat

ure

of

Prep

arer

(o

pti

on

al)

Ad

dre

ss (

Nu

mb

er, S

tree

t, C

ity,

Sta

te,

Zip

Co

de)

EDV

OTE

K, I

nc.

1467

6 R

oth

geb

Dri

veR

ock

ville

, MD

208

50

Haz

ard

ou

s C

om

po

nen

ts [

Spec

ific

C

hem

ical

Iden

tity

; C

om

mo

n N

ame(

s)]

O

SHA

PEL

AC

GIH

TLV

Oth

er L

imit

s R

eco

mm

end

ed%

(O

pti

on

al)

(301

) 25

1-59

90

(301

) 25

1-59

90

Bo

ilin

g P

oin

t

Sect

ion

III -

Ph

ysic

al/C

hem

ical

Ch

arac

teri

stic

s

Un

usu

al F

ire

and

Exp

losi

on

Haz

ard

s

Spec

ial F

ire

Fig

hti

ng

Pro

ced

ure

s

Vap

or

Pres

sure

(m

m H

g.)

Vap

or

Den

sity

(A

IR =

1)

Solu

bili

ty in

Wat

er

Ap

pea

ran

ce a

nd

Od

or

Sect

ion

IV -

Ph

ysic

al/C

hem

ical

Ch

arac

teri

stic

sFl

ash

Po

int

(Met

ho

d U

sed

)

Exti

ng

uis

hin

g M

edia

Flam

mab

le L

imit

sU

ELLE

L

Mel

tin

g P

oin

t

Evap

ora

tio

n R

ate

(Bu

tyl A

ceta

te =

1)

Spec

ific

Gra

vity

(H

0 =

1)

2

PBS

10/1

0/06

100C

No

dat

a

No

dat

a

1.01

7

No

dat

a

No

dat

a

solu

ble

solid

No

nco

mb

ust

ible

Use

ext

inq

uis

hin

g m

edia

ap

pro

pri

ate

to s

urr

ou

nd

ing

fir

e

Wea

r SC

BA

an

d p

rote

ctiv

e cl

oth

ing

to

pre

ven

t co

nta

ct w

ith

ski

n a

nd

eye

s

Emit

s to

xic

fum

es u

nd

er f

ire

con

dit

ion

s

Stab

ility

Sect

ion

V -

Rea

ctiv

ity

Dat

aU

nst

able

Sect

ion

VI -

Hea

lth

Haz

ard

Dat

a

Inco

mp

atib

ility

Co

nd

itio

ns

to A

void

Ro

ute

(s)

of

Entr

y:In

hal

atio

n?

Ing

esti

on

?Sk

in?

Oth

er

Stab

le

Haz

ard

ou

s Po

lym

eriz

atio

nM

ay O

ccu

rC

on

dit

ion

s to

Avo

id

Will

No

t O

ccu

r

Hea

lth

Haz

ard

s (A

cute

an

d C

hro

nic

)

Car

cin

og

enic

ity:

NTP

?O

SHA

Reg

ula

tio

n?

IAR

C M

on

og

rap

hs?

Sig

ns

and

Sym

pto

ms

of

Exp

osu

re

Med

ical

Co

nd

itio

ns

Gen

eral

ly A

gg

rava

ted

by

Exp

osu

re

Emer

gen

cy F

irst

Aid

Pro

ced

ure

s

Sect

ion

VII

- Pr

ecau

tio

ns

for

Safe

Han

dlin

g a

nd

Use

Step

s to

be

Take

n in

cas

e M

ater

ial i

s R

elea

sed

fo

r Sp

illed

Was

te D

isp

osa

l Met

ho

d

Prec

auti

on

s to

be

Take

n in

Han

dlin

g a

nd

Sto

rin

g

Oth

er P

reca

uti

on

s

Sect

ion

VIII

- C

on

tro

l Mea

sure

s

Ven

tila

tio

nLo

cal E

xhau

stSp

ecia

l

Mec

han

ical

(G

ener

al)

Res

pir

ato

ry P

rote

ctio

n (

Spec

ify

Typ

e)

Pro

tect

ive

Glo

ves

Oth

er P

rote

ctiv

e C

loth

ing

or

Equ

ipm

ent

Wo

rk/H

ygie

nic

Pra

ctic

es

Eye

Pro

tect

ion

Haz

ard

ou

s D

eco

mp

osi

tio

n o

r B

ypro

du

cts C

ause

eye

& s

kin

irri

tati

on

, irr

itat

ing

to

mu

cou

s m

emb

ran

es

& u

pp

er r

esp

irat

ory

tra

ct.

Toxo

colo

gic

al p

rop

erti

es h

ave

no

t b

een

th

oro

ug

hly

inve

stig

ated

.

Swal

low

ed -

was

h o

ut

mo

uth

wit

h w

ater

pro

vid

ed p

erso

n is

co

nsc

iou

s.

Skin

/eye

co

nta

ct -

flu

sh w

ith

wat

er

Inh

alat

ion

- r

emo

ve t

o f

resh

air

Yes

Y

es

Y

es

W

ear

resp

irat

or,

chem

ical

saf

ety

go

gg

les,

ru

bb

er b

oo

ts a

nd

hea

vy r

ub

ber

glo

ves,

sw

eep

up

, pla

ce in

a b

ag a

nd

ho

ld f

or

was

te d

isp

osa

l.

NIO

SH/M

SHA

ap

pro

ved

res

pir

ato

r

N/A

N/A

N/A

N/A

Yes

Yes

Do

no

t in

ges

t. A

void

co

nta

ct w

ith

ski

n, e

yes

and

clo

thin

g.

Was

h t

ho

rou

gh

ly a

fter

han

dlin

g.

Stro

ng

aci

ds

Nat

ure

of

dec

om

po

siti

on

pro

du

cts

no

t kn

ow

n

For

smal

l qu

anti

ties

- c

auti

osl

y ad

d t

o a

larg

e st

irre

d e

xces

s o

f w

ater

. A

dju

st p

H t

o n

eutr

al

Wea

r ap

pro

pri

ate

NIO

SH/M

SHA

ap

pro

ved

res

pir

ato

r, ch

emic

al r

esis

tan

t g

love

s, s

afet

y g

og

gle

ssa

fety

sh

ow

er a

nd

eye

bat

h.

ED

VO

TE

K®


Material Safety Data SheetsFull-size (8.5 x 11”) pdf copy of MSDS is available at www. edvotek.com or by request.278278

Experiment

22

1121

5th

Str

eet

NW

Was

hin

gto

n D

C 2

0001

08-1

5-11


elisa laboratory activity - images-na.ssl-images-amazon.com

Documents